TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Visual analogue scale evaluation of vaginal examination pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of the cervix with Bishop score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of the amount of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported expectations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improved Female Sexual Function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in the Intensity of Dyspareunia Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal vessel density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Choroidal vascular index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Method agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of Foreign Body Giant Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of SARS-COV-2 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: clinical stress score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure susceptibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients who quit smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Academic Impairment: Grade Point Average
Endpoint domain: Life impact
Endpoint subdomain: Academic functioning
Primary endpoint: Academic Impairment: School Attendance
Endpoint domain: Life impact
Endpoint subdomain: Academic functioning
Primary endpoint: Improvement in type 1 diabetes management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hormonal contraceptive concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: DOR concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in Semen analysis parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Average maximal peak levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average peak index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average eye blink width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASAS20 remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child and Adolescent Trauma Screen - Second Version (CATS-2 self-report)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Varicocele grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in asthenopia questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Muscle pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee joint ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of pulmonary complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ventilation distribution measured by Electrical impedance tomography (EIT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of approached patients who are eligible for and interested in participation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability as assessed by the Treatment Acceptability Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability as assessed by the System Usability Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of participants with anti-meningococcal serogroups A, C, Y, W antibody titers above predefined thresholds after 2 doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of participants with anti-meningococcal serogroups A, C, Y, W antibody titers above predefined thresholds after 3 doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cardiovascular autonomic neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: number of pediatric cases of severe community-acquired bacterial infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Residual cancer burden 0/1 (RCB-0/1) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Patient impact
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain Assessment by McGill-Melzack Pain Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life assessment by WHOQOL-BREF
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Muscle Power assessment by handheld dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rate of dentures
Endpoint domain: Mortality/survival
Primary endpoint: Psoriasis Area and Sensitivity Index (PASI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease Life Quality Index (DLQI) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 1-year Event-Free Survival (EFS) Rate
Endpoint domain: Mortality/survival
Primary endpoint: Change in observed parenting behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in self-reported parenting behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Intrauterine biomarker concentration on the day before embryo transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Intrauterine biomarker concentration on the embryo transfer day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change of liver inflammatory marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of liver fibrosis markers between baseline and week 24 after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent reduction of wound size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Participants who Complete Questionnaire
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participant Satisfaction Assessed with 5 Point Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain at Worst
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction at various intervals post op
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Full arthrokinematic sagittal ROM data at 90-days post op
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Most common adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Combined evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Feasibility of recruitment among all patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of treatment (satisfaction)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptability of TOR (attendance for patients randomized to TOR)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to composite of cardiovascular mortality, stroke, acute coronary syndrome and heart failure hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: New onset of cardiac arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cesarean hysterectomy rate
Endpoint domain: Adverse events/effects
Primary endpoint: pathologic complete response (PCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Characteristic of family
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Average change in systolic blood pressure (SBP) from baseline to 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average change in diastolic blood pressure (DBP) from baseline to 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent change of participants with controlled BP (SBP<130 and DBP<80) from baseline to 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Survival after noncurative resection
Endpoint domain: Mortality/survival
Primary endpoint: Neonatal Intensive Care Unit Parental Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Preparation for Discharge from Neonatal Intensive Care Unit and Home Care Scale
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Ankara Developmental Screening Inventory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Antibody Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Participant Satisfaction with Shared Decision Making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of parents and children enrolled in the GenV Cohort 2020s
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants with complete data collection at each wave
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants with successful data linkage at each wave
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants with the targeted biosamples received at each wave
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of Acute Myocardial Infarction (AMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MSSBP change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnosis of Pulmonary Hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Children's Depression Inventory 2nd Edition™: Self-Report Short Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Screen for Child Anxiety Related Disorders/ [General Anxiety subscale only]
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Natural progesterone blood levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Menstrual Attitude Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional and Emotional Dysmenorrhea Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Background HIV Incidence per 100-Person-Years
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants with Diagnosis of HIV-1 Infection
Endpoint domain: Mortality/survival
Primary endpoint: Changes in Musculoskeletal Health Questionnaire scores (MSK-HQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in Pain as assessed by a Visual Analogue Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival among patients receiving gemcitabine + erlotinib versus gemcitabine + erlotinib + OSI-906
Endpoint domain: Mortality/survival
Primary endpoint: Concentration of Troponin I, troponin T, hypersensitive troponin, brain natriuretic peptide and NT-proBNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Global longitudinal strain value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: The average flow velocity of the anterior descending coronary artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Delivery of prescribed fluid volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Clinically Significant Abnormalities in Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Clinically Significant Abnormalities in Laboratory Safety Tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score on the Social Responsiveness Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Changes in lung ultrasound score (LUS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in non-invasive peripheral oxygen saturation/fraction of inspired oxygen (SFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Li Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total post-operative morphine consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: percent myeloid (CD14/15) chimerism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Threshold of variation in RMSSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lupus Disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early treatment discontinuation rates
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Chronic Pain Recruited
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intervention Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Metabolic Equivalent (METs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in perceptions of care integration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Neuromotor skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of residual fluid and stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in Postpartum Depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient reported pruritus/hive score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Spirometry assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Smell and taste assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Go-No-Go task change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroop task colour words and colour blocks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N-Back task change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trail Making Test (TMT) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Digit Span task change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Card Sorting task change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary Streptococcus mutans Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Labor time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking distance (meters)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscular tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncorrected visual acuity at Visit 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of astigmatism at Visit 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child social-emotional difficulties: Problem behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child social-emotional difficulties: Depression and anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child social-emotional difficulties: Strengths and difficulties
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Systemic inflammatory response (IL-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Systemic inflammatory response (TNF-α)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Systemic inflammatory response (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Unsuccess of placement of the laryngeal mask airway
Endpoint domain: Adverse events/effects
Primary endpoint: Time spent on pre-round data gathering
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Communication accuracy during multi-disciplinary ICU rounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluable biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Side-hop test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Choice-reaction hop test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inversion-eversion force control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parents' psychological well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parenting stress
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Parents' emotion regulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total perioperative ketamine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ambulatory Blood Pressure Monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lower Extremity Functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Absence of Residual Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Intra-erythrocyte creatine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of patients requiring additional hemostatic intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Driving performance in simulator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of acute febrile cases with favorable outcome at Day 7 visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of ethinylestradiol in follicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Presence or absence of ethinylestradiol in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Presence or absence of bisphenols in follicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of bisphenols in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of glyphosate in follicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N-terminal B-type natriuretic peptide precursor (NT-proBNP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bladder colonization with Lactobacillus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Berg score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ranges of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hard Braking Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pass rate on the licensure exam
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Patient-reported bone pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of participants who complete home radon testing at 18 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants who complete home radon testing at 2 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants who request a home radon test kit at 18 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intrusion of teeth with stainless steel crown (Hall technique)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrusion of teeth with stainless steel crown (conventional technique)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance between the cusps of canines (Hall technique)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes